Rhode Island Hospital ( Site 1033) — Providence, Rhode Island

Rhode Island Hospital ( Site 1033) is a clinical research site located in Providence, Rhode Island, United States 02903.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Rhode Island Hospital ( Site 1033) has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Hypertension, Pulmonary.

Sponsors: Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Rhode Island Hospital ( Site 1033)?

Rhode Island Hospital ( Site 1033) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Rhode Island Hospital ( Site 1033) conducted?

Rhode Island Hospital ( Site 1033) has 1 clinical trials on record, with 1 currently active. Their work covers Hypertension, Pulmonary.

Is Rhode Island Hospital ( Site 1033) accredited by Crixeo Health?

Rhode Island Hospital ( Site 1033) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Rhode Island Hospital ( Site 1033)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.